XOMA Ltd opened at 2.59 on Monday. XOMA Ltd has a 1-year low of $1.04 and a 1-year high of $3.15. The company’s market cap is $176.3 million.
Separately, analysts at Ladenburg Thalmann cut their price target on shares of XOMA Ltd from $9.00 to $4.50 in a research note to investors on Tuesday, March 20th. They now have a “buy” rating on the stock.
XOMA Ltd. (XOMA) is a biopharmaceutical company focused on the discovery, development and manufacture of therapeutic antibodies designed to treat inflammatory, autoimmune, infectious and oncological diseases.